Boston Sci raises $1.9B for Endo urology buy; L'Oreal partners for 3-D printed skin;

@FierceMedDev: Adaptive Biotechnologies reels in $195M for immunosequencing tech. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Smith & Nephew boosts rep-less sales pilot by acquiring software assets that help automate training. Article | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: RainDance shoots for long reads of whole genome with Pac Bio collaboration. Item | Follow @EmilyWFierce

> Boston Scientific ($BSX) has raised $1.85 billion in debt to help financing the acquisition of the urology device portfolio from Endo International ($ENDP) for $1.6 billion. The transaction is still slated to close next quarter. More

> L'Oreal USA has partnered with 3-D bioprinting company Organovo Holdings to create 3-D printed skin tissue for product evaluation and other areas of advanced research. More

> A MarketWatch opinion piece suggests that Apple Watch and other wearables are experiencing rapid adoption among physicians. More

Biotech News

@FierceBiotech: La Jolla dumps its NASH drug and shifts its focus to rare disease. Report | Follow @FierceBiotech

@JohnCFierce: My thought: FDA panels lean on the side of approval, especially for a disease like CF. Any ??? can be answered post approval. $VRTX wins. | Follow @JohnCFierce

> MorphoSys bags a peptide biotech for $22M. Item

> FDA review challenges Vertex's case for crucial cystic fibrosis combo. Article

> Phase I safety scare costs TetraLogic a $25M fundraise. News

Pharma News

@FiercePharma: Japan's Eisai makes moves for Indian API manufacturing in further cost trimming. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: ICYMI: Valeant chief Pearson the next Warren Buffett? Deal partner Ackman thinks so. Story | Follow @CarlyHFierce

> FDA staffers raise doubts over key Vertex combo. Story

> AdverseEvents: New generation of hep C meds bests older therapies in side-effect reports. More

> Amarin sues FDA over 'free speech' issue the agency says it is ready to hash out. Article